Literatura científica selecionada sobre o tema "Kallikrein-Related peptidase 5"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Kallikrein-Related peptidase 5".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Kallikrein-Related peptidase 5"
Ismail, Maha Imam Ahmed, *. Manal Basyouni Ahmed * Manal Basyouni Ahmed e Muneera Al-Sheeha. "Evaluation of kallikrein-related peptidase 5 [KLK5] and Survivin as Prognostic Markers in Breast Cancer". International Journal of Scientific Research 3, n.º 5 (1 de junho de 2012): 398–401. http://dx.doi.org/10.15373/22778179/may2014/124.
Texto completo da fonteZingkou, Eleni, Georgios Pampalakis e Georgia Sotiropoulou. "Exacerbated dandruff in the absence of kallikrein‐related peptidase 5 protease". Journal of Dermatology 47, n.º 3 (7 de janeiro de 2020): 311–13. http://dx.doi.org/10.1111/1346-8138.15174.
Texto completo da fonteSidiropoulos, Konstantinos G., Nicole M. A. White, Anna Bui, Qiang Ding, Peter Boulos, Georgios Pampalakis, Heba Khella, Joseph N. Samuel, Georgia Sotiropoulou e George M. Yousef. "Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer". Oncoscience 1, n.º 11 (24 de outubro de 2014): 709–24. http://dx.doi.org/10.18632/oncoscience.91.
Texto completo da fonteMalachias, Apostolos, Georgia Papachristopoulou, Dimitrios Kypraios, Stefanos P. Bassioukas, Maria Nikaki, Dimitrios Xinopoulos e Maroulio Talieri. "Sa1973 Analysis and Clinical Evaluation of Kallikrein-Related Peptidase 5 (KLK5) in Colon Cancer". Gastroenterology 148, n.º 4 (abril de 2015): S—372. http://dx.doi.org/10.1016/s0016-5085(15)31246-4.
Texto completo da fonteOrtloff, A., F. A. Bustamante, L. Molina, J. Ojeda, C. D. Figueroa e P. Ehrenfeld. "Kallikrein-related Peptidase 5 (KLK5) Expression and Distribution in Canine Cutaneous Squamous Cell Carcinoma". Journal of Comparative Pathology 174 (janeiro de 2020): 113–19. http://dx.doi.org/10.1016/j.jcpa.2019.11.009.
Texto completo da fonteSakabe, Jun-ichi, Mami Yamamoto, Satoshi Hirakawa, Akira Motoyama, Isao Ohta, Kazuki Tatsuno, Taisuke Ito, Kenji Kabashima, Toshihiko Hibino e Yoshiki Tokura. "Kallikrein-related Peptidase 5 Functions in Proteolytic Processing of Profilaggrin in Cultured Human Keratinocytes". Journal of Biological Chemistry 288, n.º 24 (29 de abril de 2013): 17179–89. http://dx.doi.org/10.1074/jbc.m113.476820.
Texto completo da fonteLin, Yongbo, Li Ma, Hanliang Dan, Gang Chen, Jian Dai, Liang Xu e Yuqi Liu. "MiR-107-3p Knockdown Alleviates Endothelial Injury in Sepsis via Kallikrein-Related Peptidase 5". Journal of Surgical Research 292 (dezembro de 2023): 264–74. http://dx.doi.org/10.1016/j.jss.2023.07.013.
Texto completo da fonteYoon, Hyesook, e Isobel A. Scarisbrick. "Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis". Biological Chemistry 397, n.º 12 (1 de dezembro de 2016): 1277–86. http://dx.doi.org/10.1515/hsz-2016-0239.
Texto completo da fonteWu, Yanhua, Yingjian Chen, Qing Li, Yanwen Gong, Xiaohong Liu, Liquan Bi e Chengjin Hu. "Upregulation of kallikrein-related peptidase 5 is associated with the malignant behavior of colorectal cancer". Molecular Medicine Reports 14, n.º 3 (13 de julho de 2016): 2164–70. http://dx.doi.org/10.3892/mmr.2016.5516.
Texto completo da fontePetraki, Constantina, Youssef M. Youssef, William Dubinski, Zsuzsanna Lichner, Andreas Scorilas, Maria D. Pasic, Vassilios Komborozos et al. "Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer". Tumor Biology 33, n.º 4 (22 de março de 2012): 1209–14. http://dx.doi.org/10.1007/s13277-012-0368-5.
Texto completo da fonteTeses / dissertações sobre o assunto "Kallikrein-Related peptidase 5"
Lenga, Ma Bonda Woodys. "Rôle de la kallicréine 5 dans le remodelage de l’épithélium bronchique associé à la bronchopneumopathie chronique obstructive (BPCO)". Electronic Thesis or Diss., Tours, 2021. http://www.theses.fr/2021TOUR5001.
Texto completo da fonteChronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease mainly caused by cigarette smoking and characterized by a progressive decrease in the bronchus caliber and a mucus hypersecretion. The alteration of the pulmonary epithelium by cigarette smoke leads to the production of inflammation mediators, oxidative stress and imbalance of proteases/antiproteases well known to play a key role in the genesis and persistence of COPD. Among the protease involved, our study focused on a serine protease, kallikrein 5 (KLK5), which could play a role in tissue remodeling and repair mechanisms associated with the epithelium aggression. Our results showed, on reconstituted epithelium obtained from primary cells isolated from patients following a lung cancer surgical excision and grown in Air-Liquide Interface, that KLK5 cleaved E-cadherin and β-catenin epithelial junction proteins and altered the ultrastructure of these epitheliums. Using the 16HBE14o-bronchial cell line, strongly expressing KLK5, we have demonstrated that the invalidation of the gene for this protease increases the expression of E-cadherin and β-catenin as well as that of integrins thereby improving the integrity of the epithelial barrier and the repair of the cell monolayer. In order to study the mechanisms of action of KLK5, we also showed on BEAS-2B bronchial cells, with expressing low levels of KLK5, that this protease could be induced by pro-inflammatory cytokines (TNF, IL-8 and IL-6) and by hydrogen peroxide (H202), one of the components generated while smoking a cigarette and inducing the oxidative stress. In addition, exogenous KLK5 induces a loss of cellular adhesion to fibronectin by cleaving this matrix protein, as well as E-cadherin and integrins that allow cell to bind to the extracellular matrix. This adhesion loss, limited by the TFPI-2 that inhibits KLK5, is associated with Epithelial-Mesenchymal Transition, to increase cell migration by activating the MAPKinase signaling pathway. All of this data suggests that the activity of KLK5 produced during the inflammatory process associated with COPD would be involved in mechanisms related to the alteration and repair of the integrity of the bronchial epithelium
Wang, Ping [Verfasser], Viktor [Akademischer Betreuer] [Gutachter] Magdolen e Marion B. [Gutachter] Kiechle. "OV-MZ-6 ovarian cancer cells overexpressing kallikrein-related peptidases KLK4, 5, 6 and 7: effects on expression of cancer-related genes / Ping Wang ; Gutachter: Marion B. Kiechle, Viktor Magdolen ; Betreuer: Viktor Magdolen". München : Universitätsbibliothek der TU München, 2016. http://d-nb.info/1117796574/34.
Texto completo da fonteGong, Weiwei [Verfasser], Viktor [Akademischer Betreuer] Magdolen, Karl-Friedrich [Gutachter] Becker e Viktor [Gutachter] Magdolen. "Assessment of kallikrein-related peptidases 4, 5, 7 and 12 as prognostic biomarkers in advanced high-grade serous ovarian cancer and triple-negative breast cancer / Weiwei Gong ; Gutachter: Karl-Friedrich Becker, Viktor Magdolen ; Betreuer: Viktor Magdolen". München : Universitätsbibliothek der TU München, 2020. http://d-nb.info/1213898986/34.
Texto completo da fonteCapítulos de livros sobre o assunto "Kallikrein-Related peptidase 5"
Goettig, Peter, e Viktor Magdolen. "Kallikrein-Related Peptidase 5". In Handbook of Proteolytic Enzymes, 2772–78. Elsevier, 2013. http://dx.doi.org/10.1016/b978-0-12-382219-2.00611-6.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Kallikrein-Related peptidase 5"
Koistinen, Hannu, Mykola Domanskyy e Ulf-Håkan Stenman. "Abstract 5304: Inhibition of kallikrein-related peptidase-4 by SPINK1". In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-5304.
Texto completo da fonte